Because glucagon receptor activation can raise blood glucose in isolation, the simultaneous GLP-1 and GIP stimulation is essential to maintaining glycaemic safety which is one reason why retatrutide must only be used under close medical supervision
Keating Adis International Limited, A., New Zealand
If a second drug-induced liver injury signal emerges post-marketing on any approved small-molecule GLP-1, the regulatory and commercial framework will recalibrate sharply
Over the years, the FDA has issued hundreds of warnings about tainted weight loss products that could lead to serious health problems
But for now, the approval of Liluping as a weight-loss drug is a development big enough to shake up the industry and get a conversation started, said Li from Baird Capital
What clinical evidence supports the GLP-1 surgical hold period